Cardiogenesis Corporation (CGCPE) to Hold Q4 2007 Earnings Conference Call March 4

Cardiogenesis Corporation (OTC:CGCP) will hold a conference call on March 4 at 12:00 pm to discuss the fourth quarter earnings for 2007.

CardioGenesis engages in the design, development and distribution of laser based surgical products and disposable fiber-optic accessories to treat ischemia associated with advanced cardiovascular disease through transmyocardial revascularization (TMR) and percutaneous myocardial channeling (PMC), both of which are laser based hearth treatments in which channels are made in the heart muscle.

Both PMC and TMR have been approved by the United States Food and Drug Administration.

For more Conference Call related events or to post your own events, visit:

http://events.finditt.com/Events_List.aspx?catid=12